Back to Search
Start Over
Lenticular cytoprotection, part 2: link between glycogen synthase kinase-3β, epithelial to mesenchymal transition, and mitochondrial depolarization.
- Source :
-
Molecular vision [Mol Vis] 2014 Dec 31; Vol. 20, pp. 1758-75. Date of Electronic Publication: 2014 Dec 31 (Print Publication: 2014). - Publication Year :
- 2014
-
Abstract
- Purpose: The inhibition of GSK-3β blocks mitochondrial membrane permeability transition (mMPT) for HLE-B3 cells in atmospheric oxygen. GSK-3β, as part of a multifactorial complex, also regulates nuclear levels of β-catenin, a known coordinator of cell survival and adhesion. The purpose of these studies was to demonstrate a novel, but likely disadvantageous, link between β-catenin's influence on the expression of the pro-survival protein, vascular endothelial growth factor (VEGF), resulting in enhanced lens epithelial cell mitochondrial protection against depolarization and nuclear β-catenin as an inducer of epithelial to mesenchymal transition (EMT).<br />Methods: Virally transformed human lens epithelial cells (HLE-B3) were treated with SB216763, a specific inhibitor of GSK-3β catalytic activity and XAV939, a specific β-catenin inhibitor that bars the translocation of β-catenin from cytoplasm to the nucleus. Western blot analysis was employed to detect the levels of cytoplasmic and nuclear β-catenin and phospho-β-catenin, pBcl-2 and the EMT proteins, α-smooth muscle actin (α-SMA), and fibronectin. ELISA was used to measure the levels of VEGF in cell culture supernatants. JC-1 analysis was performed to analyze the influence of either SB216763 or XAV939 on mitochondrial depolarization.<br />Results: Cultured lens epithelial cells maintained in hypoxia (1% oxygen) and subsequently reintroduced into atmospheric oxygen and treated with the GSK-3β inhibitor SB216763 illustrated a marked inhibition of phosphorylation of glycogen synthase (downstream substrate of GSK-3β) and significant increase in nuclear translocation of β-catenin. The augmented nuclear β-catenin levels positively correlated with increased expression of α-SMA and fibronectin, both marker proteins indicative of EMT. The enhanced nuclear β-catenin activity also elicited increased VEGF and pBcl-2 expression, resulting in increased resistance to mitochondrial depolarization. Treatment of the cells with the β-catenin inhibitor XAV939 resulted in decreased expression of nuclear β-catenin, VEGF levels, pBcl-2, and EMT proteins, as well as increased mitochondrial depolarization.<br />Conclusions: The data support a model whereby the onset of epithelial to mesenchymal transition may circuitously benefit from the enhanced synthesis of VEGF by setting up a potentially harmful situation whereby the resulting mesenchymal cell population may be more resistant to mitochondrial depolarization than the lens epithelial cell population from which it originated. These findings support the potential therapeutic relevance of developing strategies to undermine the progression of normal cells to mesenchymal transition without subverting cell viability.
- Subjects :
- Animals
Cattle
Cell Hypoxia
Cell Line
Enzyme Inhibitors pharmacology
Epithelial Cells drug effects
Epithelial Cells metabolism
Epithelial Cells pathology
Glycogen Synthase Kinase 3 antagonists & inhibitors
Glycogen Synthase Kinase 3 beta
Heterocyclic Compounds, 3-Ring pharmacology
Humans
Indoles pharmacology
Lens, Crystalline drug effects
Maleimides pharmacology
Models, Biological
Protein Transport drug effects
Proto-Oncogene Proteins c-bcl-2 metabolism
Vascular Endothelial Growth Factor A metabolism
beta Catenin metabolism
Epithelial-Mesenchymal Transition drug effects
Glycogen Synthase Kinase 3 metabolism
Lens, Crystalline metabolism
Lens, Crystalline pathology
Membrane Potential, Mitochondrial drug effects
Subjects
Details
- Language :
- English
- ISSN :
- 1090-0535
- Volume :
- 20
- Database :
- MEDLINE
- Journal :
- Molecular vision
- Publication Type :
- Academic Journal
- Accession number :
- 25593505